Hiroko Ikeda

3.7k citations

57 papers · 2.4k · 1 hit paper · h-index 21

Impact in

Pharmacology top 1%
- Drug-Induced Adverse Reactions
Psychiatry and Mental health top 2%
- Epilepsy research and treatment

Papers in

Psychiatry and Mental health 16
- Epilepsy research and treatment 14
Molecular Biology 12

Co-authors: Yukitoshi Takahashi (26 shared papers)Nami Goto‐Yamamoto (1 shared paper)Puspa Raj Poudel (1 shared paper)Kazuya Koyama (1 shared paper)Michiko Aihara (4 shared papers)Masaaki Muramatsu (4 shared papers)Yoshiro Saito (4 shared papers)Nahoko Kaniwa (4 shared papers)
Journals: Brain and Development (9 papers)Epilepsia (6 papers)Epileptic Disorders (3 papers)Epilepsy & Behavior (2 papers)Neurology (2 papers)
Partner nations: Japan United States Türkiye

In The Last Decade

Hiroko Ikeda

54 papers receiving 2.4k citations

Hiroko Ikeda's Hit Papers

align trajectories log scale

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study 2016 · 519 citations

Peers

Countries citing papers authored by Hiroko Ikeda

Since Specialization

Citations

This map shows the geographic impact of Hiroko Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Ikeda more than expected).

Fields of papers citing papers by Hiroko Ikeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Ikeda. The network helps show where Hiroko Ikeda may publish in the future.

Co-authors

The 25 scholars most cited alongside Hiroko Ikeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroko Ikeda Line = papers co-authored together Hiroko Ikeda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study The Lancet ·Jacqueline A. French, John A. Lawson, Zühal Yapıcı, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J. de Vries, Dennis Dlugos, Noah Berkowitz, Maurizio Voi, Séverine Peyrard, Diana Pelov, David Neal Franz Hit paper breakdown →	2016	519
2	HLA-B Locus in Japanese Patients with Anti-Epileptics and Allopurinol-Related Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Pharmacogenomics ·Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara, Kayoko Matsunaga, Masahiro Tohkin, Kouichi Kurose, Jun‐ichi Sawada, Hirokazu Furuya, Yukitoshi Takahashi, Masaaki Muramatsu, Shigeru Kinoshita, Masamichi Abe, Hiroko Ikeda, Mariko Kashiwagi, Yixuan Song, Mayumi Ueta, Chie Sotozono, Zenrō Ikezawa, Ryuichi Hasegawa	2008	319
3	Light quality affects flavonoid biosynthesis in young berries of Cabernet Sauvignon grape Phytochemistry ·Kazuya Koyama, Hiroko Ikeda, Puspa Raj Poudel, Nami Goto‐Yamamoto	2012	231
4	HLA‐B1511* is a risk factor for carbamazepine‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis in Japanese patients Epilepsia ·Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara, Kayoko Matsunaga, Masahiro Tohkin, Kouichi Kurose, Hirokazu Furuya, Yukitoshi Takahashi, Masaaki Muramatsu, Shigeru Kinoshita, Masamichi Abe, Hiroko Ikeda, Mariko Kashiwagi, Yixuan Song, Mayumi Ueta, Chie Sotozono, Zenrō Ikezawa, Ryuichi Hasegawa	2010	168
5	A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients The Pharmacogenomics Journal ·Masahiro Tohkin, Nahoko Kaniwa, Yoshiro Saito, Emiko Sugiyama, Kouichi Kurose, Jun Nishikawa, Ryuichi Hasegawa, Michiko Aihara, Kayoko Matsunaga, Mihoko Abe, Hirokazu Furuya, Yukitoshi Takahashi, Hiroko Ikeda, Masaaki Muramatsu, Mayumi Ueta, Chie Sotozono, Shigeru Kinoshita, Zenrō Ikezawa	2011	133
6	PNES around the world: Where we are now and how we can close the diagnosis and treatment gaps—an ILAE PNES Task Force report Epilepsia Open ·Kousuke Kanemoto, W. Curt LaFrance, Roderick Duncan, David Gigineishvili, Sung‐Pa Park, Yukari Tadokoro, Hiroko Ikeda, Ravi Paul, Dong Zhou, Go Taniguchi, Mike Kerr, Tomohiro Oshima, Kazutaka Jin, Markus Reuber	2017	116
7	HLA Class I markers in Japanese patients with carbamazepine‐induced cutaneous adverse reactions Epilepsia ·Hiroko Ikeda, Yukitoshi Takahashi, Etsuko Yamazaki, Tateki Fujiwara, Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara, Mariko Kashiwagi, Masaaki Muramatsu	2009	111
8	STXBP1 mutations cause not only Ohtahara syndrome but also West syndrome—Result of Japanese cohort study Epilepsia ·Motoko Otsuka, Hirokazu Oguni, Jao‐Shwann Liang, Hiroko Ikeda, Katsumi Imai, Kyoko Hirasawa, Kaoru S. Imai, Emiko Tachikawa, Keiko Shimojima, Makiko Ōsawa, Toshiyuki Yamamoto	2010	80
9	Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial The Lancet Child & Adolescent Health ·Paolo Curatolo, David Neal Franz, John A. Lawson, Zühal Yapıcı, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Petrus J. de Vries, Dennis Dlugos, Jenna Fan, Antonia Ridolfi, Diana Pelov, Maurizio Voi, Jacqueline A. French	2018	76
10	Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan Brain and Development ·Masashi Mizuguchi, Hiroko Ikeda, Kuriko Kagitani‐Shimono, Harumi Yoshinaga, Yasuhiro Suzuki, Makoto Aoki, Masae Endo, Masataka Yonemura, Masaya Kubota	2018	59
11	An acidic and thermostable carboxymethyl cellulase from the yeast Cryptococcus sp. S-2: Purification, characterization and improvement of its recombinant enzyme production by high cell-density fermentation of Pichia pastoris Protein Expression and Purification ·Jantaporn Thongekkaew, Hiroko Ikeda, Kazuo Masaki, Haruyuki Iefuji	2008	58
12	CDKL5 alterations lead to early epileptic encephalopathy in both genders Epilepsia ·Jao‐Shwann Liang, Keiko Shimojima, Rumiko Takayama, Jun Natsume, Minobu Shichiji, Kyoko Hirasawa, Kaoru S. Imai, Tohru Okanishi, Seiji Mizuno, Akihisa Okumura, Midori Sugawara, Tomoshiro Ito, Hiroko Ikeda, Yukitoshi Takahashi, Hirokazu Oguni, Katsumi Imai, Makiko Ōsawa, Toshiyuki Yamamoto	2011	58
13	De novo variants in SETD1B are associated with intellectual disability, epilepsy and autism Human Genetics ·Takuya Hiraide, Mitsuko Nakashima, Kaori Yamoto, Tokiko Fukuda, Mitsuhiro Kato, Hiroko Ikeda, Yoko Sugie, Kazushi Aoto, Tadashi Kaname, Kazuhiko Nakabayashi, Tsutomu Ogata, Naomichi Matsumoto, Hirotomo Saitsu	2018	47
14	Fusion of cellulose binding domain from Trichoderma reesei CBHI to Cryptococcus sp. S-2 cellulase enhances its binding affinity and its cellulolytic activity to insoluble cellulosic substrates Enzyme and Microbial Technology ·Jantaporn Thongekkaew, Hiroko Ikeda, Kazuo Masaki, Haruyuki Iefuji	2013	43
15	Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations Epileptic Disorders ·Shinsaku Yoshitomi, Yukitoshi Takahashi, Tokito Yamaguchi, Taikan Oboshi, Asako Horino, Hiroko Ikeda, Katsumi Imai, Tohru Okanishi, Mitsuko Nakashima, Hirotomo Saitsu, Naomichi Matsumoto, Jun Yoshimoto, Takako Fujita, Atsushi Ishii, Shinichi Hirose, Yushi Inoue	2019	33
16	Adjunctive everolimus therapy for tuberous sclerosis complex‐associated refractory seizures: Results from the postextension phase of EXIST‐3 Epilepsia ·David Neal Franz, John A. Lawson, Zühal Yapıcı, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J. de Vries, Dennis Dlugos, Fabian Herbst, Séverine Peyrard, Diana Pelov, Jacqueline A. French	2021	26
17	Influence of CYP2C19 Polymorphism and Concomitant Antiepileptic Drugs on Serum Clobazam and N-Desmethyl Clobazam Concentrations in Patients With Epilepsy Therapeutic Drug Monitoring ·Yoshiaki Yamamoto, Yukitoshi Takahashi, Katsumi Imai, Kou Miyakawa, Shigeko Nishimura, Risa Kasai, Hiroko Ikeda, Rumiko Takayama, Yukiko Mogami, Tokito Yamaguchi, Kiyohito Terada, Kazumi Matsuda, Yushi Inoue, Yoshiyuki Kagawa	2013	26
18	A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy Brain and Development ·Tomokazu Kimizu, Yukitoshi Takahashi, Taikan Oboshi, Asako Horino, Takayoshi Koike, Shinsaku Yoshitomi, Tatsuo Mori, Tokito Yamaguchi, Hiroko Ikeda, Nobuhiko Okamoto, Mitsuko Nakashima, Hirotomo Saitsu, Mitsuhiro Kato, Naomichi Matsumoto, Katsumi Imai	2016	25
19	Cloning and characterization of a novel phytase from wastewater treatment yeast Hansenula fabianii J640 and expression in Pichia pastoris Journal of Bioscience and Bioengineering ·Takashi Watanabe, Hiroko Ikeda, Kazuo Masaki, Tsutomu Fujii, Haruyuki Iefuji	2009	22
20	Risk factors of cognitive impairment in pediatric epilepsy patients with focal cortical dysplasia Brain and Development ·Nobusuke Kimura, Nobusuke Kimura, Yukitoshi Takahashi, Hideo Shigematsu, Katsumi Imai, Hiroko Ikeda, Hideyuki Ootani, Rumiko Takayama, Yukiko Mogami, Noriko Kimura, Koichi Baba, Kazumi Matsuda, Takayasu Tottori, Naotaka Usui, Satohiko Kondou, Yushi Inoue	2018	21

About Hiroko Ikeda

Hiroko Ikeda is a scholar working on Psychiatry and Mental health, Molecular Biology, Pediatrics, Perinatology and Child Health, Physiology and Genetics, having authored 57 papers that have together received 2.4k indexed citations. Recurring topics across this work include Epilepsy research and treatment (14 papers), Pharmacological Effects and Toxicity Studies (7 papers), Tuberous Sclerosis Complex Research (6 papers), Drug-Induced Adverse Reactions (5 papers), Genetics and Neurodevelopmental Disorders (5 papers), Biofuel production and bioconversion (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Urticaria and Related Conditions (3 papers). The work is most often cited by research in Pharmacology (621 citations), Psychiatry and Mental health (437 citations), Toxicology (68 citations), Rheumatology (260 citations) and Physiology (442 citations). Hiroko Ikeda has collaborated with scholars based in Japan, United States and Türkiye. Frequent co-authors include Yukitoshi Takahashi, Nami Goto‐Yamamoto, Puspa Raj Poudel, Kazuya Koyama, Michiko Aihara, Masaaki Muramatsu, Yoshiro Saito, Nahoko Kaniwa, Petrus J. de Vries and Rima Nabbout. Their work appears in journals such as Brain and Development, Epilepsia, Epileptic Disorders, Epilepsy & Behavior and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Hiroko Ikeda

Impact in

Papers in i

In The Last Decade

Hiroko Ikeda

Hiroko Ikeda's Hit Papers

Peers

Countries citing papers authored by Hiroko Ikeda

Fields of papers citing papers by Hiroko Ikeda

All Works

About Hiroko Ikeda

Explore authors with similar magnitude of impact

Papers in